Follow The Filings

MESO Mesoblast

Mesoblast earnings company data as of 4:48 AM ET 9/11

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q2 4 Sep EPS 0.00 — —
Rev — — —

Insider trades

Open-market buys and sales by MESO's executives, directors and 10% owners in the last 12 months, from their Form 4s

All MESO insider trades
  • $37.5M bought by 1 insider
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Gregory George Director
    Buy
    $11.4M 7,910,962 shares at $1.44 +1915% to stake
    Traded Apr 4–10 Filed Apr 13
    ↗
  2. Gregory George Director
    Buy
    $26.1M 8,305,962 shares at $3.15 +45864% to stake
    Traded Apr 4–10 Filed Apr 10
    ↗

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
20-F Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc

Source: SEC EDGAR submissions, updated 4 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.